+33 (0)6 47 17 67 07 contact@nexialist.fr
  • 
  •  Contact
  • Français
  • English
Nexialist - votre partenaire pour la conformité des dispositifs médicaux
  • The company
    • Discover Nexialist
    • Our team of experts
    • Recruitment area
  • Your needs
  • Our solutions
    • Phaos – NEW
    • PYXIS
    • nex’inform
    • Our solutions
  • News & Uptades
    • MDCG
    • Artificial Intelligence
    • Clinical evaluation
    • Corporate
    • Digital health
    • Electrical devices
    • Innovation
    • PMS / PMCF
    • Process / Production
    • Quality
    • Regulation
    • Risk management
    • Software
    • Technical documentation
    • Unique Device Identification System (UDI System)
    • GLOSSARY
Select Page

MDCG 2024-10 – Clinical evaluation of orphan medical devices – June 2024

25 Jun 2024 | All the News, MDCG

Theme Clinical evaluation Target Audience Manufacturers, NB Products concerned Orphan medical devices Documents mentioned MDR (EU) 2017/745 – article 60 Article 35 of the Charter of Fundamental Rights states These are guidelines for manufacturers and notified bodies...

MDCG  2024-9 – Preliminary re-assessment review template – IVDR (Regulation (EU) 2017/746)  – May 2024

23 May 2024 | MDCG

Theme Re-assessment of notified bodies  Target Audience Designating authority, NB  Products concerned IVD Documents mentioned IVDR (EU) 2017/746 article 40(10) MDCG 2022-13  This document is a template form to be used by the designating authority in the context of the...

MDCG  2024-8 – Preliminary assessment review template – IVDR (Regulation (EU) 2017/746) – May 2024

23 May 2024 | MDCG

Theme Assessment of notified bodies  Target Audience Designating authority, NB  Products concerned IVD Documents mentioned IVDR (EU) 2017/746 – article 35 MDCG 2022-13  This guidance document is a form template to be used by the designating authority in the context of...

MDCG  2024-7 – Preliminary assessment review (PAR) form template (MDR) – May 2024.

23 May 2024 | MDCG

Theme Assessment of notified bodies  Target Audience Designating authority, NB  Products concerned MD Documents mentioned MDR (EU) 2017/745 – article 39 MDCG 2022-13  This guidance document is a form template to be used by the designating authority as part of the...

MDCG  2024-6 – Preliminary re-assessment review template – MDR (Regulation (EU) 2017/745)  – May 2024

23 May 2024 | MDCG

Theme Re-assessment of notified bodies  Target Audience Designating authority, NB  Products concerned MD Documents mentioned MDR (EU) 2017/745 article 46 MDCG 2022-13  This document provides a template form for use by designating Authorities (NAs) in the reassessment...
« Older Entries
Next Entries »

Search in the Website

All the topics

  • Clinical evaluation
  • Corporate
  • Digital health
  • Electrical devices
  • Innovation
  • MDCG
  • PMS / PMCF
  • Process / Production
  • Quality
  • Regulation
  • Risk management
  • Unique Device Identification System (UDI System)

#Tags

Animal origin Biocompatibility Borderline Classification Clinical trials Datas Homologation Labeling Matières premières Medical devices Mise sur le marché Placing on the market Qualification Retraitement Sterilization Usability

Archives

Contact us

Le Forum Bat B
515 Avenue de La Tramontane
13600 La Ciotat
FRANCE

+33 (0)4 42 01 60 29
Write us

Nexialist

Nexialist : Intelligence règlementaire et conformité des produits de santé

About us

Nexialist works with companies in the medical device sector, including in vitro diagnostic and advanced therapy devices. We provide assistance with any compliance, quality, and regulatory-related challenges as well as product development and commercialisation strategy.

Legal informations

  • Privacy policy
  • Legal notice
  • Sitemap

Nexialist’s universe

  • NEXIALIST
  • NEXINFORM

Follow us on…

© NEXIALIST - Réalisation : Nathalie Brunelli, Mirobolus 2019